Cost Plus Drugs Founder Mark Cuban: How AI Can Uncover Healthcare Contract Black Boxes and Trust Crises
US venture capital firm a16z released a new podcast featuring Cost Plus Drugs co-founder Mark Cuban alongside hosts Julie Yoo and Erik Torenberg. Cuban suggests employers use AI to review benefits contracts to identify unfair pricing, while sharing his strategy of making 'trust' the core product and discussing healthcare transparency trends.
US venture capital firm Andreessen Horowitz (a16z) published a podcast episode on October 28, 2026, focusing on healthcare costs and artificial intelligence applications. The guest is Mark Cuban, co-founder of Cost Plus Drugs, hosted by a16z General Partner Julie Yoo and Erik Torenberg.
According to the official show notes, Cuban believes that while AI could transform healthcare, it won't fix opaque prices and broken incentives on its own. He offers a specific starting point for employers: run every benefits contract through AI and ask where you're getting ripped off.
The episode also explores what Cuban has learned building Cost Plus Drugs, why trust is its core product, and how greater transparency could put pressure on healthcare costs. Topics include personalized medicine, the changing role of doctors, and why founders should use AI to learn rather than as an excuse to stop thinking.